Antibodies to watch in 2024
51:01
Trends in the commercial development of antibody therapeutics: The early-stage clinical pipeline
43:28
Strategies for Mitigating the Unpredictability of Fc-Mediated Functions in Antibody Development
52:50
Exploring TCR-Epitope Prediction Tools: Insights And Pitfalls
1:21:32
Antibody–Drug Conjugates for Solid Tumors: Progress, Possibilities, and Implications for Care
54:39
Innovative Technologies for Antibody Discovery, Transforming Hit Generation & Lead Characterization
59:06
3D antibody modeling in Orion
49:58
Harnessing Divergent Species to Access Difficult and Conserved Antibody Targets
27:03